News in brief: Althea completes medical cannabis asset sales; Argent begins clinical supply in Slovenia; ECS backs UWA trial for sleep apnoea by Adam Sheldon July 8, 2025July 9, 2025 Althea has completed the $1 million sale of its medicinal cannabis assets to Tasmanian Botanics – […]
Argent Biopharma and Auscann sign deal to ‘enhance drug development’ by Steve Jones April 23, 2025April 23, 2025
News in brief: TGA ponders rule change; no repeal of German law; Argent signs Malta deal; new role for Kylie O’Brien by Steve Jones April 10, 2025April 10, 2025
News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal by Steve Jones and Martin Lane April 3, 2025April 3, 2025
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Poor share trading and lack of interest in capital raise sees Argent seek delisting from ASX by Steve Jones August 15, 2024August 15, 2024
Company news: Zelira Therapeutics; Ecofibre; Cann Group; InhaleRx; Argent Biopharma; Melodiol Global Health; Wellnex Life by Steve Jones July 4, 2024November 25, 2024
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
